Lucid Diagnostics Inc.

LUCD Nasdaq SEC CIK 1799011
Follow Lucid Diagnostics Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $1.2M −0.7% vs same quarter last year
Net income −$6.7M +35.8% vs same quarter last year
EPS, diluted −$0.03 +70% vs same quarter last year
Operating cash flow −$15.6M −42.8% vs same quarter last year
Revenue by quarter
$1.2M
$828K
$1.2M
$1.2M
$1.5M
$1.3M
$1.5M
$1.2M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income7 fiscal years
  • Revenue
  • Net income
−$60M−$40M−$20M$0$20MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$4.7M−$58M
FY24$4.3M−$45.5M
FY23$2.4M−$52.7M
FY22$377K−$56.2M
FY21$500K−$28.1M
FY20-−$8.3M
FY19--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−15000%−10000%−5000%0%5000%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY25−41.7%−1054.8%−1232.7%
FY24−63.3%−1059.6%−1047.6%
FY23-−1996.8%−2169.1%
FY22100%−14920.7%−14899.5%
FY21100%−5483.8%−5615.6%
FY20---
FY19---
Free cash flowOperating cash flow minus capital expenditure
−$60M−$40M−$20M$0FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$46.7M
FY24−$44.4M
FY23-
FY22−$32.9M
FY21−$18.5M
FY20-
FY19-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Lucid Diagnostics
  • Healthcare median
−15000%−10000%−5000%0%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearLucid DiagnosticsHealthcare median
FY25−1232.7%−30.6%
FY24−1047.6%−47%
FY23−2169.1%−58%
FY22−14899.5%−80.4%
FY21−5615.6%−71.8%
FY20-−62.2%
FY19-−46.2%